The Concept of Early Vascular Ageing – An Update in 2015

Arterial ageing is a process that can be quantified, at least to some degree, by measurement of pulse wave velocity along the aorta, the largest elastic artery, as a marker of arterial stiffness. In recent years the new concept of early vascular ageing (EVA) has been developed by a group of mostly E...

Full description

Bibliographic Details
Main Author: Peter M. Nilsson
Format: Article
Language:English
Published: European Medical Journal 2015-11-01
Series:European Medical Journal Diabetes
Subjects:
Online Access:http://emjreviews.com/wp-content/uploads/The-Concept-of-Early-Vascular-Ageing-An-Update-in-2015.pdf
id doaj-43c6189f604f488b93ffac30fe6f171b
record_format Article
spelling doaj-43c6189f604f488b93ffac30fe6f171b2020-11-25T01:48:25ZengEuropean Medical JournalEuropean Medical Journal Diabetes2054-61812015-11-01318086The Concept of Early Vascular Ageing – An Update in 2015Peter M. Nilsson0Lund University, Malmö, Sweden Arterial ageing is a process that can be quantified, at least to some degree, by measurement of pulse wave velocity along the aorta, the largest elastic artery, as a marker of arterial stiffness. In recent years the new concept of early vascular ageing (EVA) has been developed by a group of mostly European researchers and some reviews have been published. Based on a lecture given at the European Association for the Study of Diabetes (EASD) Meeting in Vienna 2014, this review was written to describe recent developments in research dedicated to EVA and new emerging aspects found in studies of families at high cardiovascular (CV) risk. This brings new perspectives related to genetics, telomere biology, and the role of gut microbiota. Even if EVA has been described in general terms there is still no unifying definition available and no direct treatment, only recommendations for conventional CV risk factor control. However, a new intervention study (SPARTE) is ongoing in France with a randomised design to treat arterial stiffness in patients with hypertension versus conventional treatment strategies. Results are expected in a few years and will be of importance in defining the role of arterial stiffness, a core feature of EVA, as a target for treatment.http://emjreviews.com/wp-content/uploads/The-Concept-of-Early-Vascular-Ageing-An-Update-in-2015.pdfArterial ageingarterial stiffnessblood pressure (BP)glycaemiaHypertensionlipidsMicrobiotatelomere
collection DOAJ
language English
format Article
sources DOAJ
author Peter M. Nilsson
spellingShingle Peter M. Nilsson
The Concept of Early Vascular Ageing – An Update in 2015
European Medical Journal Diabetes
Arterial ageing
arterial stiffness
blood pressure (BP)
glycaemia
Hypertension
lipids
Microbiota
telomere
author_facet Peter M. Nilsson
author_sort Peter M. Nilsson
title The Concept of Early Vascular Ageing – An Update in 2015
title_short The Concept of Early Vascular Ageing – An Update in 2015
title_full The Concept of Early Vascular Ageing – An Update in 2015
title_fullStr The Concept of Early Vascular Ageing – An Update in 2015
title_full_unstemmed The Concept of Early Vascular Ageing – An Update in 2015
title_sort concept of early vascular ageing – an update in 2015
publisher European Medical Journal
series European Medical Journal Diabetes
issn 2054-6181
publishDate 2015-11-01
description Arterial ageing is a process that can be quantified, at least to some degree, by measurement of pulse wave velocity along the aorta, the largest elastic artery, as a marker of arterial stiffness. In recent years the new concept of early vascular ageing (EVA) has been developed by a group of mostly European researchers and some reviews have been published. Based on a lecture given at the European Association for the Study of Diabetes (EASD) Meeting in Vienna 2014, this review was written to describe recent developments in research dedicated to EVA and new emerging aspects found in studies of families at high cardiovascular (CV) risk. This brings new perspectives related to genetics, telomere biology, and the role of gut microbiota. Even if EVA has been described in general terms there is still no unifying definition available and no direct treatment, only recommendations for conventional CV risk factor control. However, a new intervention study (SPARTE) is ongoing in France with a randomised design to treat arterial stiffness in patients with hypertension versus conventional treatment strategies. Results are expected in a few years and will be of importance in defining the role of arterial stiffness, a core feature of EVA, as a target for treatment.
topic Arterial ageing
arterial stiffness
blood pressure (BP)
glycaemia
Hypertension
lipids
Microbiota
telomere
url http://emjreviews.com/wp-content/uploads/The-Concept-of-Early-Vascular-Ageing-An-Update-in-2015.pdf
work_keys_str_mv AT petermnilsson theconceptofearlyvascularageinganupdatein2015
AT petermnilsson conceptofearlyvascularageinganupdatein2015
_version_ 1725012101594873856